Patent ID: 11918728
Assignee: IMMUTRIX THERAPEUTICS, INC.
Field: Chemical engineering (Chemistry)
Classification: CPC A  B | IPC A  B

Claim 0:
1. A method of treating a subject infected with SARS-CoV-2 comprising:
obtaining a bodily fluid from the subject having a level of COVID-19 disease mediators (y);
contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate;
contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the weight ratio of SCP to anion exchange resin is from about 1:100 to produce a second filtrate;
contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the weight ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and
administering the third filtrate to the subject.